Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 70518-3850

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 70518-3850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for esomeprazole magnesium 40 mg delayed-release capsules, containing 30 capsules per package. The label shows the product as Rx only, with NDC 70518-3850-00, manufactured by Biocon Pharma in Iselin, NJ, and repackaged by RemedyRepack Inc. in Indiana, PA. Storage instructions and a QR code are also present.*

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 01)

Chemical structure of esomeprazole magnesium presented as two aromatic rings with attached functional groups including methoxy, methyl, and sulfoxide, and associated magnesium ion with three water molecules.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (B201c94c 128a 4ae1 86a1 057c4c895839 02)

A line chart showing the percentage of esomeprazole magnesium delayed-release capsules 40 mg remaining over a 6-month period compared to placebo. Four groups are plotted: three with esomeprazole magnesium (sample sizes 91, 92, 98) and one placebo group (n=94). The y-axis represents percent maintained from 0 to 100%, and the x-axis represents months from 0 to 6. The esomeprazole groups maintain higher percentages over time compared to placebo, which decreases more sharply.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (B201c94c 128a 4ae1 86a1 057c4c895839 03)

A line graph showing the percent maintenance over six months for Esomeprazole Magnesium Delayed-Release Capsules in strengths of 40 mg, 20 mg, and 10 mg compared to placebo. The y-axis represents percent maintained, and the x-axis represents months, from 1 to 6, illustrating higher maintenance rates for 40 mg capsules versus lower strengths and placebo.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) Figure (B201c94c 128a 4ae1 86a1 057c4c895839 04)

A line graph showing the percentage of patients symptom-free over 28 days for esomeprazole magnesium delayed-release capsules at 40 mg and 20 mg doses compared to placebo. The x-axis represents diary days (0 to 28), and the y-axis represents percent of patients symptom-free (0% to 100%).*

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 05)

A line graph showing the percentage of patients symptom-free over 28 diary days for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The vertical axis represents the percent of patients symptom-free, and the horizontal axis shows diary days from 0 to 28, with data points illustrating trends for each group over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.